Stock Screener App

무료 -

설치하다

12.06

0.50% 0.06

Liquidia Corp (LQDA)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Liquidia Corp 주식(LQDA)의 최신 뉴스

Wells Fargo Raises Price Target for Liquidia (LQDA) to $25 | LQD - GuruFocus

Liquidia (LQDA): B of A Securities Lowers Price Target to $23 | LQDA Stock News - GuruFocus

# Raymond James reiterates Strong Buy on Liquidia stock amid competition - Investing.com

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings - GuruFocus

# Raymond James reiterates Strong Buy on Liquidia stock amid competition By Investing.com - Investing.com UK

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings | LQDA Stock News - GuruFocus

Treprostinil Saga Continues - JD Supra

Liquidia at Jefferies Conference: Strategic Moves in PAH Market - Investing.com

BTIG Raises Liquidia Price Target Following YUTREPIA Approval - Insider Monkey

Judge Denies UTC Bid To Block Liquidia's Lung Drug - Law360

Liquidia (LQDA) Stock Price Target Raised by Analyst | LQDA Stoc - GuruFocus

Raymond James maintains strong buy on Liquidia stock following court ruling By Investing.com - Investing.com South Africa

BTIG raises Liquidia stock price target following FDA approval By Investing.com - Investing.com South Africa

Raymond James maintains strong buy on Liquidia stock following court ruling - Investing.com India

BTIG raises Liquidia stock price target following FDA approval - Investing.com

Liquidia Beats UTC Bid to Block Launch of Lung Drug Yutrepia - Bloomberg Law News

Liquidia stock rises following YUTREPIA shipment news By Investing.com - Investing.com Canada

Liquidia stock rises following YUTREPIA shipment news - Investing.com

Needham raises Liquidia Technologies stock price target after court ruling By Investing.com - Investing.com South Africa

Needham raises Liquidia Technologies stock price target after court ruling - Investing.com

Liquidia (LQDA) Gets Price Target Boost from Needham | LQDA Stock News - GuruFocus

Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension - marketscreener.com

Liquidia starts commercial shipment of FDA-approved YUTREPIA By Investing.com - Investing.com India

Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following L - GuruFocus

Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following Legal Victory | LQDA Stock News - GuruFocus

Liquidia starts commercial shipment of FDA-approved YUTREPIA - Investing.com

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD - The Manila Times

BTIG reaffirms buy rating for Liquidia stock amid legal developments By Investing.com - Investing.com South Africa

Gold Is Bullish, But Be Aware Of Deeper Intraday Pullback; Elliott Wave Intraday Analysis - The Globe and Mail

BTIG reaffirms buy rating for Liquidia stock amid legal developments - Investing.com

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - mx.advfn.com

Liquidia Told to Swap Two Defenses Ahead of Trial on UTC Patent - Bloomberg Law News

Liquidia (NASDAQ:LQDA) Given New $23.00 Price Target at Wells Fargo & Company - Defense World

Wells Fargo lifts Liquidia stock price target to $23 from $20 By Investing.com - Investing.com South Africa

H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod By Investing.com - Investing.com South Africa

Liquidia (NASDAQ:LQDA) Given New $35.00 Price Target at HC Wainwright - Defense World

Scotiabank Raises Price Target for Liquidia (LQDA) to $37.00 | LQDA Stock News - GuruFocus

These Analysts Boost Their Forecasts On Liquidia - Benzinga

Scotiabank Increases Price Target for Liquidia (LQDA) After Yutrepia Approval | LQDA Stock News - GuruFocus

Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analy - GuruFocus

Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analyst | LQDA Stock News - GuruFocus

Liquidia Technologies stock target raised to $33 at Raymond James - Investing.com

Breaking Down Liquidia: 12 Analysts Share Their ViewsLiquidia (NASDAQ:LQDA) - Benzinga

Liquidia (LQDA) Price Target Raised to $35 by HC Wainwright | LQ - GuruFocus

H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod - Investing.com

Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQ - GuruFocus

Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch By Investing.com - Investing.com South Africa

Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch - Investing.com

Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQDA Stock News - GuruFocus

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference - Yahoo Finance

Liquidia (LQDA) Gains FDA Approval, Price Target Raised to $23 | - GuruFocus

Liquidia (LQDA) Gains FDA Approval, Price Target Raised to $23 | LQDA Stock News - GuruFocus

Needham Reiterates Buy Rating on LQDA with a Price Target of $25 - GuruFocus

Wells Fargo lifts Liquidia stock price target to $23 from $20 - Investing.com

Needham Reiterates Buy Rating on LQDA with a Price Target of $25.00 | LQDA Stock News - GuruFocus

Jefferies Boosts Liquidia (LQDA) Price Target After FDA Approval - GuruFocus

BTIG raises Liquidia stock price target to $37, maintains buy - Investing.com

Liquidia (LQDA) Sees Price Target Boost After FDA Approval | LQD - GuruFocus

Liquidia (LQDA) Sees Price Target Boost After FDA Approval | LQDA Stock News - GuruFocus

Jefferies raises Liquidia Technologies stock target to $31 - Investing.com

Jefferies Boosts Liquidia (LQDA) Price Target After FDA Approval | LQDA Stock News - GuruFocus

GMAB

$20.44

1.45%

RPRX

$36.19

0.86%

SMMT

$22.62

6.70%

INSM

$98.24

0.64%

BNTX

$108.26

0.70%

ONC

$244.32

0.34%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개